Liposome circulation time and tumor targeting: implications for cancer chemotherapy
- 1 September 1995
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 16 (2-3) , 285-294
- https://doi.org/10.1016/0169-409x(95)00030-b
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Doxorubicin Encapsulated in Long-Circulating Thermosensitive LiposomesJournal of Liposome Research, 1994
- Preclinical Studies with Doxorubicin Encapsulated in Polyethyleneglycol-Coated LiposomesJournal of Liposome Research, 1993
- Gelation of liposome interior A novel method for drug encapsulationFEBS Letters, 1992
- In vitro cytotoxicity of liposome-encapsulated doxorubicin: dependence on liposome composition and drug releaseBiochimica et Biophysica Acta (BBA) - Biomembranes, 1992
- Sterically stabilized liposomesBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1992
- Tumor accumulation of novel RES-avoiding liposomesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1992
- Drug-polymer conjugatesAnti-Cancer Drugs, 1992
- Role of liposome size and RES blockade in controlling biodistribution and tumor uptake of GM1-containing liposomesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1992
- Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis.Journal of Clinical Investigation, 1989
- Liposomal Blockade of the Reticuloendothelial System: Improved Tumor Imaging with Small Unilamellar VesiclesScience, 1983